BMY

65.89

0.64% 0.42

시장 영업 전: 65.67 -0.22 -0.33%

브리스톨 마이어스 스퀴브 (BMY)

개요 뉴스 가격 이력 옵션 체인 Financials BMY 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$65.47

열려 있는:

$64.89

하루 거래량:

23.28M

Relative Volume:

2.06

시가총액:

$134.55B

수익:

$48.48B

순이익/손실:

$7.27B

주가수익비율:

18.49

EPS:

3.5626

순현금흐름:

$11.91B

1주 성능:

+3.60%

1개월 성능:

+13.35%

6개월 성능:

+14.35%

1년 성능:

+45.13%

1일 변동 폭

$63.87

$66.31

1주일 범위

$62.23

$68.10

52주 변동 폭

$42.52

$68.10

브리스톨 마이어스 스퀴브 Stock (BMY) Company Profile

명칭

Bristol Myers Squibb Co

부문

Healthcare (1080)

산업

Drug Manufacturers - General (20)

전화

(609) 252-4621

주소

ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY

직원

32,500

트위터

@BMSNEWS

다음 수익 날짜

2026-07-30

최신 SEC 제출 서류

BMY's Discussions on Twitter

Compare BMY vs LLY, JNJ, ABBV, MRK, NVS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
BMY Bristol Myers Squibb Co	65.89	127.75B	48.48B	7.27B	11.91B	3.5626
LLY Lilly Eli Co	1,115.68	1.07T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	254.93	640.91B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	243.80	453.91B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	128.00	322.95B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	153.27	296.72B	54.66B	13.58B	16.05B	7.0171

브리스톨 마이어스 스퀴브 Stock (BMY) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-02-25	개시	RBC Capital Mkts	Sector Perform
2026-02-20	개시	Barclays	Overweight
2026-01-07	업그레이드	UBS	Neutral → Buy
2025-12-15	업그레이드	BofA Securities	Neutral → Buy
2025-12-12	업그레이드	Guggenheim	Neutral → Buy
2025-11-13	개시	Scotiabank	Sector Perform
2025-08-05	다운그레이드	Daiwa Securities	Outperform → Neutral
2025-04-22	개시	Cantor Fitzgerald	Neutral
2025-04-22	개시	Piper Sandler	Overweight
2024-12-16	업그레이드	Jefferies	Hold → Buy
2024-12-10	재개	BofA Securities	Neutral
2024-11-15	개시	Wolfe Research	Peer Perform
2024-11-13	업그레이드	Daiwa Securities	Neutral → Outperform
2024-11-12	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-25	다운그레이드	Citigroup	Buy → Neutral
2024-10-17	개시	Bernstein	Mkt Perform
2024-07-29	다운그레이드	Barclays	Overweight → Equal Weight
2024-03-11	다운그레이드	Societe Generale	Buy → Hold
2024-02-06	다운그레이드	Redburn Atlantic	Buy → Neutral
2024-01-03	다운그레이드	BofA Securities	Buy → Neutral
2023-11-15	다운그레이드	Cantor Fitzgerald	Overweight → Neutral
2023-11-09	개시	Deutsche Bank	Hold
2023-11-02	다운그레이드	Daiwa Securities	Outperform → Neutral
2023-10-27	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2023-10-27	업그레이드	HSBC Securities	Reduce → Hold
2023-10-27	다운그레이드	William Blair	Outperform → Mkt Perform
2023-10-20	재개	UBS	Neutral
2023-07-14	개시	HSBC Securities	Reduce
2023-07-10	개시	SVB Securities	Market Perform
2023-06-28	개시	Daiwa Securities	Outperform
2023-03-06	개시	Jefferies	Hold
2023-01-17	개시	Cantor Fitzgerald	Overweight
2022-11-18	개시	Credit Suisse	Neutral
2022-10-10	다운그레이드	Guggenheim	Buy → Neutral
2022-09-14	다운그레이드	Berenberg	Buy → Hold
2022-06-03	다운그레이드	Raymond James	Outperform → Mkt Perform
2022-04-06	재개	Morgan Stanley	Underweight
2021-12-17	개시	Goldman	Buy
2021-12-09	재개	Wells Fargo	Equal Weight
2021-11-19	개시	BMO Capital Markets	Outperform
2021-11-01	다운그레이드	Argus	Buy → Hold
2021-07-27	재개	Truist	Buy
2021-04-30	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-04-13	업그레이드	Truist	Hold → Buy
2020-11-16	업그레이드	Societe Generale	Hold → Buy
2020-11-10	재개	Bernstein	Mkt Perform
2020-11-06	다운그레이드	Gabelli & Co	Buy → Hold
2020-10-19	업그레이드	Guggenheim	Neutral → Buy
2020-09-29	개시	Berenberg	Buy
2020-07-28	개시	Raymond James	Outperform
2020-04-02	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2020-03-23	다운그레이드	Societe Generale	Buy → Hold
2020-02-27	개시	Barclays	Equal Weight
2020-01-06	재개	Citigroup	Buy
2019-12-13	업그레이드	Argus	Hold → Buy
2019-11-22	재개	Morgan Stanley	Equal-Weight
2019-10-17	재개	BofA/Merrill	Buy
2019-08-14	업그레이드	Atlantic Equities	Neutral → Overweight
2019-05-28	개시	Goldman	Buy
2019-05-20	다운그레이드	Argus	Buy → Hold
2019-05-03	업그레이드	Barclays	Equal Weight → Overweight
2019-05-03	재개	JP Morgan	Overweight
2019-01-15	업그레이드	Societe Generale	Sell → Buy
2018-10-22	다운그레이드	Citigroup	Buy → Neutral

모두보기

브리스톨 마이어스 스퀴브 주식(BMY)의 최신 뉴스

Jul 28, 2026

New Iza-bren Approvals Underscore China's Rising Role In Bispecific ADCs - Benzinga

Jul 28, 2026

Legal intelligence start-up Theo Ai appoints former Bristol Myers Squibb GC to board of directors - The Global Legal Post

Jul 28, 2026

Jul 27, 2026

Bristol-Myers Squibb stock rating held at Market Perform by Raymond James - Investing.com

Jul 27, 2026

Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings? - TradingView

Jul 27, 2026

Theo Ai Appoints Ex-Bristol Myers Squibb GC To Board - Law360

Jul 27, 2026

Theo Ai Appoints Former Bristol Myers Squibb General Counsel Sandra Leung to Board - citybiz

Jul 27, 2026

Bristol-Myers Squibb stock hits 52-week high at 62.89 USD - Investing.com

Jul 27, 2026

BMO reiterates Bristol-Myers Squibb stock rating on Cobenfy edge - Investing.com

Jul 27, 2026

BMO reiterates Bristol-Myers Squibb stock rating on Cobenfy edge By Investing.com - Investing.com India

Jul 27, 2026

Theo Ai Appoints Former Bristol Myers Squibb General Counsel Sandra Leung to Board of Directors - citybiz

Jul 27, 2026

Bristol Myers Squibb stock holds gains as Takeda partnership and Revlimid erosion shape outlook - Ad-hoc-news.de

Jul 27, 2026

Theo Ai Bolsters Leadership, Appoints Sandra Leung, Former Bristol Myers Squibb General Counsel, to Board of Directors - PR Newswire

Jul 27, 2026

BMS launches dual immunotherapy for metastatic melanoma - The Hindu

Jul 27, 2026

Jul 26, 2026

Bristol Myers Squibb stock reacts to latest Opdivo data and solid 2024 outlook - Ad-hoc-news.de

Jul 26, 2026

BMY|Bristol-Myers Squibb Co|Price:62.090|Chg%:+0.580 - TradingKey

Jul 26, 2026

Bristol Myers Squibb stock trades steadily as Eliquis and Opdivo anchor earnings and guidance - Ad-hoc-news.de

Jul 26, 2026

Jul 25, 2026

Why is Barclays Bullish on Bristol-Myers Squibb (BMY) Now - Kavout | AI

Jul 25, 2026

Bristol Myers Squibb stock reacts as cancer and cardiovascular pipeline updates follow recent earnin - Ad-hoc-news.de

Jul 25, 2026

Bristol-Myers Squibb Co (BMY) Income Statement - TradingKey

Jul 25, 2026

Bristol-Myers Squibb Co (BMY) Cash Flow - TradingKey

Jul 25, 2026

Bristol-Myers Squibb’s High Dividend Temporarily Backed by Financial Support, but Patent Cliff Poses Future Concerns - NAI500

Jul 25, 2026

Jul 24, 2026

Is Bristol Myers Squibb's Dividend Too Good to Be True? Here's My Honest Answer - The Motley Fool

Jul 24, 2026

Is Bristol Myers Squibb's Dividend Too Good to Be True? Here's My Honest Answer - The Motley Fool

Jul 24, 2026

Bristol-Myers Squibb Co (BMY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 24, 2026

Bristol-Myers Squibb Co (BMY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 24, 2026

Bristol-Myers Squibb Company (BRM.F) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Jul 24, 2026

BMY|Bristol-Myers Squibb Co|Price:62.560|Chg%:+0.470 - TradingKey

Jul 24, 2026

Bristol-Myers Squibb stock trades steady as Opdivo and Eliquis underpin revenue and margins - Ad-hoc-news.de

Jul 24, 2026

Bristol Myers Squibb stock steadies as investors weigh Karuna buyout and latest oncology data - AD HOC NEWS

Jul 24, 2026

Oak Associates Ltd. OH Acquires New Position in Bristol Myers Squibb Company $BMY - MarketBeat

Jul 24, 2026

Public Employees Retirement System of Ohio Has $51.79 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat

Jul 24, 2026

Why Investors Are Watching Bristol Myers Squibb, Gilead Sciences and Amgen - Kalkine Media

Jul 24, 2026

Bristol Myers Squibb Company $BMY Stake Raised by Sei Investments Co. - MarketBeat

Jul 24, 2026

Why Is Bristol Myers Squibb (NYSE:BMY) On S&P 500 Radar? - Kalkine Media

Jul 24, 2026

Compound Planning Inc. Has $4.94 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

Jul 24, 2026

Arrowstreet Capital Limited Partnership Has $538.13 Million Stake in Bristol Myers Squibb Company $BMY - MarketBeat

Jul 24, 2026

Bristol-Myers Squibb Co (BMY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 24, 2026

Bristol Myers Squibb stock trades steady as cardiovascular and oncology pipeline shapes outlook - AD HOC NEWS

Jul 24, 2026

Jul 23, 2026

Bristol-Myers Squibb Company (BMY) Options Chain - Yahoo! Finance Canada

Jul 23, 2026

Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Jul 23, 2026

DOL Brief Sides With Bristol-Myers in PRT Appeal - planadviser

Jul 23, 2026

Bristol Myers Squibb stock steadies as investors weigh Revlimid erosion against new product launches - AD HOC NEWS

Jul 23, 2026

Jul 22, 2026

DOL Anchors Wave of Briefs Backing Bristol-Myers in PRT Appeal - plansponsor

Jul 22, 2026

DOL Takes Swipe At Derisking Cases In Bristol-Myers Brief - Law360

Jul 22, 2026

Bristol Myers Squibb stock stabilizes as Eliquis and Opdivo help offset Revlimid erosion - AD HOC NEWS

Jul 22, 2026

Donald TrumpBRISTOL MYERS SQUIBB CO Trump Trade on May. 18, 2026 - Quiver Quantitative

Jul 22, 2026

Bristol Myers Squibb stock steadies as Eliquis and Opdivo shape earnings outlook - AD HOC NEWS

Jul 22, 2026

Bristol Myers Squibb (BMY) Wins FDA Filing And Nvidia Tie Up, Is It Still Undervalued? - simplywall.st

Jul 22, 2026

Alexandria Real Estate Equities (ARE) Delivers 427,000 RSF Bristol Myers Squibb R And D Hub - Yahoo Finance Singapore

Jul 22, 2026

Bristol Myers Squibb stock edges higher as recent results and oncology portfolio shape investor view - AD HOC NEWS

Jul 22, 2026

Bristol Myers Squibb Partners With NVIDIA to Build Pharma's Largest Supercomputer - Mjengo Hub

Jul 22, 2026